Evidence map›Paper›PMID 32298803›Full record

ReviewBrain, behavior, and immunity2020

Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.

Emily A Troyer, Jordan N Kohn, Suzi Hong

Registry-linked trialAbstract readReview
In one paragraph

Review in Brain, behavior, and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04397328 (Safety and Efficacy of Post-exposure Prophylaxis With Hydroxychloroquine), which is not on this map. Cited by 473 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
473citing papers in PubMed, 7 pooled it
79.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04397328 phase3withdrawnnot on this map

Safety and Efficacy of Post-exposure Prophylaxis With Hydroxychloroquine (HCQ) for the Prevention of COVID-19 in High-risk Older Individuals in Long-term and Specialized Care: A Double-blind Randomized Control Trial

TypeinterventionalSponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRan2020 to 2021Enrolled0ConditionsCOVID-19ArmsHydroxychloroquine, Placebo
3 · Its place in the literature

Who cites it

473 citing papers in PubMed, 7 syntheses or guidelines pooled it, 982 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. SARS-CoV-2 Infection and the Risk of Suicidal and Self-Harm Thoughts and Behaviour: A Systematic Review.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2022
    Pooled it
  5. Pooled it
  6. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2022
    Pooled it
  7. Pooled it
  8. Trial
  9. Experiences of people with long COVID: Symptoms, support strategies and the Long COVID Optimal Health Programme (LC-OHP).Health expectations : an international journal of public participation in health care and health policy · 2024
    Trial
  10. The Nexus of Sports-Based Development and Education of Mental Health and Physical Fitness.International journal of environmental research and public health · 2023
    Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. Impact of COVID-19 on Mental Health: Sociodemographic Differences and the Moderating Effect of Religiosity.International journal of environmental research and public health · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

413 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emily A TroyerDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr. MC0804, La Jolla, CA 92093-0804, USA. Electronic address: etroyer@health.ucsd.edu.
Jordan N KohnDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr. MC0804, La Jolla, CA 92093-0804, USA. Electronic address: jokohn@health.ucsd.edu.
Suzi HongDepartment of Psychiatry, University of California San Diego, 9500 Gilman Dr. MC0804, La Jolla, CA 92093-0804, USA; Department of Family Medicine and Public Health, Department of Psychiatry, University of California San Diego, 9500 Gilman Dr. MC0804, La Jolla, CA 92093-0804, USA. Electronic address: s1hong@health.ucsd.edu.
University of California, San Diego · US

Funding

FELLOWSHIP IN GERIATRIC MENTAL HEALTHT32MH019934 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Elizabeth W Twamley · 1994 to 2026
$9.5M
Fellowship on Biological Psychiatry and NeuroscienceT32MH018399 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Pei-an (Betty) Shih · 1986 to 2026
$7.3M
Autonomic and Immuno-vascular Mechanisms of Antihypertensive Effects of TaichiR01HL126056 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HONG, SUZI, REDWINE, LAURA S · 2015 to 2019
$3.6M
UC San Diego Clinical and Translational Research InstituteTL1TR001443 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2019
$3.4M
Multisystem risk profile of older adults to predict cognitive function and impairmentR03AG063328 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HONG, SUZI · 2019 to 2021
$472k
NCATS NIH HHS TL1 TR001443NHLBI NIH HHS R01 HL126056NIA NIH HHS R03 AG063328NIMH NIH HHS T32 MH018399NIMH NIH HHS T32 MH019934
6 · The paper itself

Abstract

The coronavirus disease 19 (COVID-19) pandemic is a significant psychological stressor in addition to its tremendous impact on every facet of individuals' lives and organizations in virtually all social and economic sectors worldwide. Fear of illness and uncertainty about the future precipitate anxiety- and stress-related disorders, and several groups have rightfully called for the creation and dissemination of robust mental health screening and treatment programs for the general public and front-line healthcare workers. However, in addition to pandemic-associated psychological distress, the direct effects of the virus itself (several acute respiratory syndrome coronavirus; SARS-CoV-2), and the subsequent host immunologic response, on the human central nervous system (CNS) and related outcomes are unknown. We discuss currently available evidence of COVID-19 related neuropsychiatric sequelae while drawing parallels to past viral pandemic-related outcomes. Past pandemics have demonstrated that diverse types of neuropsychiatric symptoms, such as encephalopathy, mood changes, psychosis, neuromuscular dysfunction, or demyelinating processes, may accompany acute viral infection, or may follow infection by weeks, months, or longer in recovered patients. The potential mechanisms are also discussed, including viral and immunological underpinnings. Therefore, prospective neuropsychiatric monitoring of individuals exposed to SARS-CoV-2 at various points in the life course, as well as their neuroimmune status, are needed to fully understand the long-term impact of COVID-19, and to establish a framework for integrating psychoneuroimmunology into epidemiologic studies of pandemics.

Indexed as

Acute DiseaseAnxietyBacterial TranslocationBetacoronavirusChronic DiseaseCoronavirus InfectionsCOVID-19Cytokine Release SyndromeDemyelinating DiseasesDepressionHumansImmunologic FactorsMental DisordersMental HealthNervous System DiseasesNeurodegenerative DiseasesImmunologic FactorsCoronavirus pandemicCOVID-19Post-viral neuropsychiatric sequelaePublic mental health

Identifiers

PMID32298803
PMCPMC7152874
OpenAlexW3015706105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.